Abstract
Currently available treatment options are unlikely to be curative for the majority of multiple myeloma patients, emphasizing a continuing role for the introduction of investigational agents that can overcome drug resistance. The canonical Wnt/β-catenin signaling pathway, essential for self-renewal, growth, and survival, has been found to be dysregulated in multiple myeloma, particularly in advanced stages of disease. This provides the rationale for evaluating the novel β-catenin inhibitor BC2059 as monotherapy and in combination with proteasome inhibitors in vitro and in vivo Here, we show nuclear localization of β-catenin in human myeloma cell lines (HMCL), consistent with activation of the canonical Wnt pathway. BC2059 attenuates β-catenin levels, in both the cytoplasm and the nucleus, reducing the transcriptional activity of the TCF4/LEF complex and the expression of its target gene axin 2. Treatment of HMCL with BC2059 inhibits proliferation and induces apoptosis in a dose-dependent manner. This is also observed in HMCL-stromal cell cocultures, mitigating the protective effect afforded by the stroma. Similarly, BC2059 induces apoptosis in primary multiple myeloma samples in vitro, causing minimal apoptosis on healthy periph...Continue Reading
References
Apr 5, 2000·The Journal of Biological Chemistry·U SteinhusenK Bommert
Mar 12, 2003·The EMBO Journal·Ho-Geun YoonJiemin Wong
Mar 12, 2003·Oncogene·Ya-Wei QiangStuart Rudikoff
Feb 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·Desheng LuDennis A Carson
Apr 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Patrick W B DerksenSteven T Pals
Apr 15, 2005·Nature·Tannishtha Reya, Hans Clevers
May 12, 2006·Leukemia·L YsebaertC Racaud-Sultan
Feb 24, 2007·The EMBO Journal·Addolorata Maria Luce ColucciaCarlo Gambacorti-Passerini
Apr 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kumar SukhdeoDaniel R Carrasco
Jun 8, 2007·Leukemia·J-H MikeschC Müller-Tidow
Sep 21, 2007·Leukemia·C S ChimR Liang
Dec 21, 2007·Blood·Claire M EdwardsGregory R Mundy
Jan 15, 2008·Nature Cell Biology·Jiong Li, Cun-Yu Wang
Mar 18, 2008·Blood·Ya-Wei QiangShmuel Yaccoby
May 20, 2008·Leukemia Research·Lili ZhouHua Jiang
Nov 28, 2008·British Journal of Haematology·Matthias SchmidtIngo G H Schmidt-Wolf
Jul 22, 2009·Developmental Cell·Bryan T MacDonaldXi He
Dec 8, 2009·Blood·James J DriscollNikhil C Munshi
Feb 26, 2010·The Journal of Biological Chemistry·Yoana N DimitrovaWalter J Chazin
Mar 18, 2011·The New England Journal of Medicine·Antonio Palumbo, Kenneth Anderson
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Constantine S MitsiadesPaul G Richardson
Jul 23, 2011·Molecular Cell·Hyo-Kyoung ChoiHo-Geun Yoon
Dec 17, 2011·Leukemia·T C LuisF J T Staal
Mar 1, 2012·PloS One·Kinga A KocembaSteven T Pals
Jul 26, 2012·Blood Cancer Journal·H YaoT Maekawa
Sep 18, 2012·Blood Cancer Journal·J E NollA C W Zannettino
Dec 22, 2012·Nature Reviews. Cancer·Jamie N Anastas, Randall T Moon
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Giacomo DonatiFiona M Watt
Jun 1, 2014·Marine Drugs·Seoyoung ParkSangtaek Oh
Dec 9, 2014·Leukemia·W FiskusK N Bhalla
Jan 31, 2015·PloS One·Eileen R GrigsonYulia Nefedova
Citations
Jun 26, 2018·International Journal of Molecular Sciences·Sridurga MithraprabhuAndrew Spencer
Feb 23, 2019·Journal of the National Cancer Institute·Motonari NomuraJason T Yustein
Mar 3, 2018·Blood·Steven Grant
Nov 14, 2019·Current Pharmaceutical Design·Morteza GhandadiSorour Ashari
Mar 14, 2020·British Journal of Haematology·Haiqin WangXiaojuan Xiao
Dec 24, 2018·Leukemia·Dyana T SaenzKapil N Bhalla
Sep 26, 2019·Frontiers in Oncology·Xiao-Guang YangDun Wang
Jul 19, 2020·International Journal of Molecular Sciences·Sabah AkhtarShahab Uddin
Nov 15, 2019·Molecular Cancer·Xueting HuMinghui Wang
May 7, 2020·Frontiers in Genetics·Meral BeksacDilara Akcora Yildiz
May 20, 2018·Journal of Hematology & Oncology·Ingrid SpaanVictor Peperzak
Sep 28, 2020·Journal of Cancer Research and Clinical Oncology·Andrés Cardona-Echeverry, Jeanette Prada-Arismendy
Feb 17, 2019·Leukemia·Harmen van AndelSteven T Pals
Nov 3, 2020·Leukemia & Lymphoma·Antonia RealeAndrew Spencer
Jan 8, 2021·Frontiers in Oncology·Michela Frenquelli, Giovanni Tonon
Feb 14, 2021·Proteomics·Antonia RealeAndrew Spencer
Mar 16, 2021·Current Oncology Reports·Ravin RatanAndrew J Bishop
Jun 29, 2021·Frontiers in Cell and Developmental Biology·Ling ZhangJia-Jun Liu
Jul 25, 2021·Cancers·Wancheng GuoXiaojuan Xiao
Mar 7, 2019·Oncology Research·Yulong JinXiequn Chen